Aurora Cannabis Inc (ACB.TO) is on the rise, with shares climbing 1.08% in the latest trading session, reflecting strong performance driven by international medical sales.
In the latest trading session, Aurora Cannabis Inc (ACB.TO) saw its stock price increase by 1.08%, closing at CA$4.20. This uptick is attributed to the company’s robust quarterly performance, particularly in its medical cannabis segment, which has shown significant growth in international markets.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Aurora Cannabis Inc
ACB.TO
ACB.TO
Aurora Cannabis Inc
WealthAwesomeMarket cap
$240.34M
52W high
$9.33
52W low
$3.59
1W change
+2.92%
Beta
1.35
Analyst Price Targets
Based on analyst covering ACB
Wall Street analysts forecast ACB stock price to rise 45.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.64
+45.4% Upside
Current Price
C$3.88
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ACB's historical volatility
30-Day Vol
34.7%
Annualized
90-Day Vol
48.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$3.25
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.66 | C$3.24 – C$4.12 |
| 60 trading days | C$3.44 | C$2.91 – C$4.08 |
| 90 trading days | C$3.25 | C$2.64 – C$3.99 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should take note of Aurora's strategic pivot towards international medical cannabis markets, which is driving revenue growth despite challenges in the Canadian consumer segment.
ACB's Revenue Grows 11% Year-Over-Year
Aurora Cannabis reported a net revenue of C$320.6 million for FY26, exceeding management's expectations and reflecting strong international sales.
Bull case
Aurora's recent quarterly results show impressive growth in medical cannabis revenue, which rose by 18% year-over-year. This growth highlights the success of its global strategy. Notably, 55% of its revenue now comes from outside Canada, positioning the company to take advantage of international demand.
Bear case
Despite the positive revenue growth, Aurora faces challenges in the Canadian market. A significant pricing reset and declining consumer cannabis sales could impact overall profitability in the short term. Investors should be aware of these potential hurdles.
Strong Quarterly Performance
Advertisement
Aurora Cannabis reported a remarkable 11% increase in net revenue for FY26, reaching C$320.6 million. This growth was primarily driven by an 18% rise in medical cannabis revenue, which now constitutes 91% of the company's total net revenue. The strategic focus on international markets has allowed Aurora to generate approximately 55% of its revenue outside Canada, indicating a successful shift towards higher-margin medical cannabis.
Challenges in the Canadian Market
While Aurora's international sales are thriving, the company is facing significant challenges in the Canadian consumer cannabis market. The decision to wind down lower-margin consumer operations is expected to impact short-term revenue. Additionally, a pricing reset due to changes in Canadian reimbursement policies could further affect profitability. Investors should remain cautious about these potential headwinds.
Future Growth Prospects
Looking ahead, Aurora Cannabis is well-positioned for long-term growth, especially with its recent acquisition of Safari Flower Company, which enhances its capabilities in the European market. The company maintains a strong financial position with substantial liquidity and no debt, allowing it to pursue further growth opportunities and navigate market fluctuations effectively.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
